Purpose-built for physicians GLP-1, SGLT2 combination therapy provides largest weight loss for women with PCOS Combination therapy with a GLP-1 receptor agonist and an SGLT2 inhibitor may provide better weight-loss benefits than a single agent for women with polycystic ovary syndrome and obesity, according to study data
This allows us to tailor the GLP-1 Peptide protocol specifically for you, integrating it with nutrition and lifestyle guidance
1113-1124, Mosenzon, O., et al
Combine this with the dehydration commonly caused by these medications , and you can experience significant full-body aches, leg cramps, and injection-site soreness
Ethical Concerns: Diverting from evidence-based treatments can lead to worsening health conditions and missed opportunities for proper care